GSK plc Reversal Of Inventory Writedown
GSK plc (GLAXF) reported Reversal Of Inventory Writedown of GBP 575.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes › Inventory
ifrs-full:ReversalOfInventoryWritedown · last filed 2026-03-06
| Period end | Reversal Of Inventory Writedown 12 month | Reversal Of Inventory Writedown 12 month as first filed |
|---|---|---|
| 2025-12-31 | 575.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 630.00M GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | 598.00M GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | 483.00M GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | 325.00M GBP 20-F · filed 2024-03-05 | 384.00M GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 250.00M GBP 20-F · filed 2023-03-10 | 274.00M GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 230.00M GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | 302.00M GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | 352.00M GBP 20-F · filed 2020-03-06 | |
| 2016-12-31 | 145.00M GBP 20-F · filed 2019-03-15 | |
| 2015-12-31 | 65.00M GBP 20-F/A · filed 2018-03-20 |